SCHEMBL3383580

SCHEMBL3383580

O=C(N[C@@H](CCO)c1ccccc1)[C@@H]1SCCN1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKACA P17612 1/20 0.40
CDK8 P49336 1/20 0.40
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
PRKX P51817 1/20 0.40
PRKCQ Q04759 1/20 0.40
ROCK1 Q13464 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
PTGFR P43088 1/20 0.40
CFD P00746 1/20 0.38
KCNQ3 O43525 1/20 0.38
KCNQ2 O43526 1/20 0.38
CCR5 P51681 4/20 0.38
PHGDH O43175 1/20 0.38
RPS6KB1 P23443 2/20 0.37
TACR3 P29371 1/20 0.37
AKT1 P31749 1/20 0.37
ROCK2 O75116 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7045396 1.00 PRKACA (0.40) PRKACACDK8GSK3AGSK3BPRKX
SCHEMBL3386255 0.90 PTGFR (0.46) PTGFRCFDCCR5RPS6KB1WDR91
SCHEMBL3382787 0.85 CFD (0.40) PTGFRCFD
SCHEMBL13004626 0.85 PTGFR (0.39) PRKACACDK8GSK3AGSK3BPRKX
SCHEMBL3386859 0.85 PTGFR (0.39) PRKACACDK8GSK3AGSK3BPRKX
SCHEMBL3385956 0.85 PTGFR (0.39) PRKACACDK8GSK3AGSK3BPRKX
SCHEMBL3383891 0.80 JAK2 (0.38) PTGFRCFD
SCHEMBL3382557 0.78 PTGFR (0.64) PRKACACDK8GSK3AGSK3BPRKX
SCHEMBL3382579 0.78 PTGFR (0.64) PRKACACDK8GSK3AGSK3BPRKX
SCHEMBL3382653 0.78 PTGFR (0.64) PRKACACDK8GSK3AGSK3BPRKX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415480-B2 Thiazolidine carboxamide derivatives as modulators of the prostaglandin F receptor MERCK SERONO SA (CH) 2013-04-09 US disclosed
EP-1487442-B1 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR MERCK SERONO SA (CH) 2010-12-01 EP disclosed
US-20090215749-A9 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR LABORATOIRES SERONO S.A. (CH) 2009-08-27 US disclosed
US-20080255094-A1 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR LABORATOIRES SERONO S.A. (CH) 2008-10-16 US disclosed
US-20050215605-A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor MERCK SERONO SA (CH) 2005-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215749-A9 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR PTGER4, PTGER2, PTGER1 PRKACA 1689/4885CDK8 1324/4885GSK3A 4404/4885
US-20080255094-A1 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR PTGER4, PTGER2, PTGER1 PRKACA 1689/4885CDK8 1324/4885GSK3A 4404/4885
US-20050215605-A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor TBXA2R, CNR2, PTGDR PRKACA 2577/4885CDK8 1143/4885GSK3A 4874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.